32 0

Vascular smooth muscle dysfunction induced by monomethylarsonous acid (MMA(III)): A contributing factor to arsenic-associated cardiovascular diseases

Title
Vascular smooth muscle dysfunction induced by monomethylarsonous acid (MMA(III)): A contributing factor to arsenic-associated cardiovascular diseases
Author
배옥남
Keywords
Smooth muscle dysfunction; Arsenic; Monomethylarsonous acid (MMA(III)); Vasoconstriction; Cardiovascular diseases
Issue Date
2008-11
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Citation
ENVIRONMENTAL RESEARCH, v. 108, No. 3, Page. 300-308
Abstract
While arsenic in drinking water is known to cause various cardiovascular diseases in human, exact mechanism still remains elusive. Recently, trivalent-methylated arsenicals, the metabolites of inorganic arsenic, were shown to have higher cytotoxic potential than inorganic arsenic. To study the role of these metabolites in arsenic-induced cardiovascular diseases, we investigated the effect of monomethylarsonous acid (MMA(III)), a major trivalent-methylated arsenical, on vasomotor tone of blood vessels. In isolated rat thoracic aorta and small mesenteric arteries, MMA(III) irreversibly suppressed normal vasoconstriction induced by three distinct agonists of phenylephrine (PE), serotonin and endothelin-1. Inhibition of vasoconstriction was retained in aortic rings without endothelium, suggesting that MMA(III) directly impaired the contractile function of vascular smooth muscle. The effect of MMA(III) was mediated by inhibition of PE-induced Ca2+ increase as found in confocal microscopy and fluorimeter in-lined organ chamber technique. The attenuation of Ca2+ increase was from concomitant inhibition of release from intracellular store and extracellular Ca2+ influx via L-type Ca2+ channel, which was blocked by MMA(III) as shown in voltage-clamp assay in Xenopus oocytes. MMA(III) did not affect downstream process of Ca2+, as shown in permeabilized arterial strips. In in vivo rat model, MMA(III) attenuated PE-induced blood pressure increase indeed, supporting the clinical relevance of these in vitro findings. In conclusion, MMA(III)-incluced smooth muscle dysfunction through disturbance of Ca2+ regulation, which results in impaired vasoconstriction and aberrant blood pressure change. This study will provide a new insight into the role of trivalent-methylated arsenicals in arsenic-associated cardiovascular diseases. (C) 2008 Elsevier Inc. All rights reserved.
URI
https://www.sciencedirect.com/science/article/pii/S0013935108001424http://repository.hanyang.ac.kr/handle/20.500.11754/80789
ISSN
0013-9351
DOI
10.1016/j.envres.2008.06.012
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE